Pharma’s Cutting Edge

Pharma’s Cutting Edge

Pharmaceutical and biotech science and business

 
 
 
 

Ariad Patent Re-Examined

Ariad’s Patent Eviscerated. In the Pipeline:  As you’ll read in Derek Lowe’s post, The USPTO has completed its patent re-examination of Ariad’s patent that is under dispute in the lawsuit of Ariad v Lilly.  See my post from late June discussing Lilly’s appeal of the jury verdict in this case. 

Leave a Reply

You must be logged in to post a comment.

Pages

Recent Posts

Popular Posts

Pharma's Cutting Edge Archives

Categories

Meta

Blogroll

Syndicate

  • Subscribe to my feed